| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |